Come celebrate the launch of Fida Neo, hear about what in-solution kinetics Can do for you, get a glass of champagne and a Fida In-solution cake! #biologics2024 #insolutionkinetics

The day has come! 🍾 Meet #FidaNeo - the new generation of #FIDA Technology instrument. It is an in-solution technology, thus it frees the users from inconveniences of surface-based technologies, such as surface regeneration or steric hindrance. Fida Neo has no restrictions on

What drug discoveries could you make if you could study kinetics in-solution? Adopting new technologies is a pathway to pioneering new discoveries and ways of working. If you ever feel constrained by rigid requirements for specific buffer, ionic strength, detergents or the need

How important is it to measure protein aggregates in dairy industry? Highly, especially if the matter involves infant formula 🍼 . Baby formulas are made using hydrolyzed cow's milk proteins, thus measuring aggregation is crucial due to #Allergenic Potential, Sensitising

How to analyse small molecule interactions with #membrane #proteins? Absolute size and Binding Related Intensity Change allow to measure the subtle changes of ligand-free and bound states - FIDA can deliver these orthogonal measurements based on a single data set. Learn more:

Have you seen the new publication on thermodynamic characterization of amyloid polymorphism by microfluidic transient incomplete separation? @DTUtweet in @RoySocChem using #FIDA .

We're looking forward to @CHI_Healthtech Peptalk in #SanDiego! Our highlight is a presentation by @DTUtweet's professor Steffen Goletz on Generation of Robust Bispecific Antibodies through Fusion of Single-Domain #Antibodies on IgG Scaffolds. What is yours?

Dear users, it is time to sing up for Fidabio User Group meeting 2024! Few last speaking slots remain available, so if you want to make sure your research is seen, hurry up:.

RT @BindingLeeds: Fida has been great for telling us when proteins are behaving badly. Adding glycerol "just in case" induced protein agg….

Developments in Neurodegenerative Disease Research #Parkinsons - BRICHOS can effectively target and suppress secondary nucleation processes on fibril surfaces and inhibit the elongation of fibril ends. We're thrilled, read more: . @biorxivpreprint.

Congratulations to researchers from DTU, for a new publication in the Journal of Analytical Chemistry. We are glad to see that Fida 1 enables researchers like you to stimulate development in drug manufacturing industry. #academia #innovation #firstprinciples #protein #Biotech

We are happy to share that The Francis Crick Institute, a Biomedical Research Centre in London, UK has adopted the #Fida 1 technology as part of their Structural Biology Science Technology Platform headed by Dr Philip Walker. Glad to support you in your #research!

How do you make the best out of your FIDA 1 platform?.Learn, network and develop by attending FIDA Advanced Course on November 24-25th. Sign up on: #fida #professionaldevelopment #innovation #LifeSciences #biophysics #protein #development

Yehudah Pardo, Senior Expert | Data Science in Novartis NIBR and Henrik Jensen, CSO of Fidabio, are presenting how #FIDA is applied in #TPD research, in the 5th Targeted Protein Degradation Summit. Learn more: . #Summit #Hansonwade #molecular #glues

#Fidabio is exhibiting at #ELRIGDD22. Pass by booth C30 to learn about Fida 1, and don’t miss out our 5 min spotlight with title “Flow Induced Dispersion Analysis (FIDA) Protein QC: Linking absolute hydrodynamic radius determination to structural insight.”

This week, #Fidabio is in Belgium in the Leuven Protein Aggregation Meeting presenting the poster “Rapid characterization of Liquid-Liquid Phase Separation with #FIDA”. Find us on the ground floor in the sponsor posters area. #ProAgg22 #Protein #Aggregation #LLPS

Fidabio is joining the Leuven Protein Aggregation Meeting #PROAGG22 starting on Sep 21. Hasse Hedeby will be on-site to present how researchers use Fida 1 to measure multiple parameters of Liquid-Liquid Phase Separation which is associated with various #neurologicaldisorders.

Fida1 provides in-solution characterization of ternary complex formation. Determining size, affinities, and cooperativity in a single run from just a few nL of sample, it is ideal for drug screening and orthogonal characterization. Application Note:

The PDB Correlator uses X-ray, Cryo-EM or AlphaFold structural data to predict the Rh of molecules and, thereby, give information on oligomeric status. Read the App Note to see how it is used to determine the in-solution oligomeric status of proteins.

New article presenting #nanobody-based protein #therapeutics against α-cobratoxin, a #neurotoxin from cobra Naja kaouthia. FIDA is used to characterize the binding of a panel of Quads against the toxin. Read the article here: